Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha TeknovaTKNO +0.56%63 Current Ratio is 4.59 as of Mar. 2026, which is 17% below its 10-year median of 5.52. GuruFocus rates TKNO with a GF Score™ of 63/100 and a GF Value™ of $3.55 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 998 Drug Manufacturers companies, Alpha Teknova ranks better than 82.97% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Alpha Teknova's current ratio for the quarter that ended in Mar. 2026 was 4.59.
Alpha Teknova has a current ratio of 4.59. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Alpha Teknova's Current Ratio or its related term are showing as below:
TKNO'
s Current Ratio Range Over the Past 10 Years
Min: 1.5 Med: 5.52 Max: 19.92
Current: 4.59
During the past 7 years, Alpha Teknova's highest Current Ratio was 19.92. The lowest was 1.50. And the median was 5.52.
TKNO's Current Ratio is ranked better than 82.97% of 998
companies
in the Drug Manufacturers industry
Industry Median: 2
vs TKNO: 4.59
Alpha Teknova (NAS:TKNO) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Alpha Teknova Current Ratio Related Terms
Alpha Teknova Current Ratio Historical Data
* Premium members only.
The historical data trend for Alpha Teknova's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TKNO vs AKBA, ORGO, SIGA: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alpha Teknova's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Teknova Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alpha Teknova's Current Ratio distribution charts can be found below:
* The bar in red indicates where Alpha Teknova's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Teknova (TKNO) has a Current Ratio of 4.59 as of Mar. 2026. This is 17% below median its historical median of 5.52. Over the past decade, Alpha Teknova's Current Ratio has ranged from 1.50 to 19.92. According to the industry distribution chart, Alpha Teknova ranks #170 out of 998 companies in the Drug Manufacturers industry, placing it in the top 17%.
Is Alpha Teknova's Current Ratio too high?
Alpha Teknova's current Current Ratio of 4.59 is 17% below median its 10-year median of 5.52. Over the past 10 years, this metric has ranged from a low of 1.50 to a high of 19.92. The Drug Manufacturers industry median Current Ratio is 2.00. Alpha Teknova's value of 4.59 is 129.5% above this industry median. Based on the distribution chart, Alpha Teknova ranks #170 out of 998 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Alpha Teknova has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alpha Teknova's Current Ratio compare to AKBA and ORGO?
According to the Drug Manufacturers industry distribution chart, Alpha Teknova ranks #170 out of 998 companies for Current Ratio. This places Alpha Teknova in the top 17% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.00. Alpha Teknova's value of 4.59 is 129.5% above this benchmark. Historically, Alpha Teknova's own Current Ratio has ranged from 1.50 to 19.92 over the past decade. While the company's 10-year median is 5.52 vs. the industry median of 2.00, Alpha Teknova has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Teknova's current Current Ratio of 4.59 is 129.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Teknova's current Current Ratio is 4.59, which is 17% below median its own 10-year median of 5.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Teknova stock overvalued right now?
Based on GuruFocus' analysis, Alpha Teknova (TKNO) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.55, compared to a current price of $5.34 — trading 50.4% above its estimated fair value. The current Current Ratio is 4.59, which is 17% below median its 10-year median of 5.52 and 129.5% above the Drug Manufacturers industry median of 2.00. Alpha Teknova's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Alpha Teknova (TKNO), the current Current Ratio is 4.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpha Teknova (TKNO) Overvalued in 2026?
Based on GuruFocus' analysis, Alpha Teknova stock appears to be overvalued.
The current stock price of $5.34 is trading 50.4% above its estimated GF Value™ of $3.55.
GuruFocus considers Alpha Teknova to be Significantly Overvalued.
Key valuation signals for TKNO:
Current Ratio: 4.59 (17% below median its 10-year median of 5.52)
GF Value™: $3.55 vs. price of $5.34 (50.4% above fair value)
Industry Position: 129.5% above the Drug Manufacturers median (#170 of 998)
No single metric tells the full story. See the TKNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
63GF Score
Get the complete analysis for TKNO
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TKNO has been successfully added to your 
